GB Patent

GB0228079D0 — Huntington's Disease

Assigned to Laxdale Ltd · Expires 2003-01-08 · 23y expired

What this patent protects

Analysis of the huntington gene provides a method for identifying patients likely to respond to treatment of Huntington's disease with eicosapentaenoic acid, EPA.

USPTO Abstract

Analysis of the huntington gene provides a method for identifying patients likely to respond to treatment of Huntington's disease with eicosapentaenoic acid, EPA.

Drugs covered by this patent

Patent Metadata

Patent number
GB0228079D0
Jurisdiction
GB
Classification
—
Expires
2003-01-08
Drug substance claim
No
Drug product claim
No
Assignee
Laxdale Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.